GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Puravankara Ltd

Puravankara re-appoints Ashish Ravi Puravankara as MD for 5 years from April 2026

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 20 Mar 2026, 01:45 PM IST  ·  BSE ID: 84a104e7-dc8d-47ca-b193-8a815f8fd0bd
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board member and top executive keeps his job for another five years, with a pay raise approved by shareholders.
🤖 AI Summary
  • Ashish Ravi Puravankara re-appointed Managing Director for 5 years from April 1, 2026, to March 31, 2031
  • Remuneration enhanced for 3-year period April 1, 2026, to March 31, 2029
  • Shareholder approval granted via Postal Ballot dated March 19, 2026, based on Board February 12 recommendation
  • Company operates 9 cities: Bengaluru, Mumbai, Pune, Goa, Hyderabad, Chennai, Kochi, Coimbatore, Mangaluru
🔢 Key Numbers - exact figures from BSE filing, not rounded
MD re-appointment term
5 years, April 1, 2026, to March 31, 2031
Enhanced remuneration period
3 years, April 1, 2026, to March 31, 2029
Operating cities
9 cities (Bengaluru, Mumbai, Pune, Goa, Hyderabad, Chennai, Kochi, Coimbatore, Mangaluru)
🏢 How This Affects the Company
📈
Business Impact
MD continuity ensures sustained strategic direction across real estate portfolio spanning nine Indian cities and newly entered Mumbai redevelopment market.
💰
Financial Impact
Enhanced remuneration increases MD compensation outflow for the 3-year period ending March 31, 2029.
⚙️
Operational Impact
Leadership continuity under a 5-year mandate provides operational stability and oversight of construction quality, innovation deployment, and project completion across residential and commercial segments.
👥 What This Means For Shareholders
✅
Action Required
No action required. Shareholder approval already obtained via Postal Ballot dated March 19, 2026.
👤
Who Is Affected
All shareholders hold equity in a company now committed to MD leadership continuity through March 31, 2031. Enhanced MD remuneration reduces distributable cash for 3 years ending March 2029.
🔍
Management Signal
Board and shareholders backing MD's strategic vision confirms confidence in current leadership's execution of multi-city residential-commercial pipeline.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q4 FY26 results announcement — track project completions and revenue recognition trends across nine-city portfolio
Annual report FY26 filing — confirm enhanced MD remuneration disclosure and compensation details for 3-year period
Mumbai redevelopment project launches — monitor new project announcements under confirmed MD leadership through 2031
LOW RISK Management continuity reduces leadership transition risk. No governance flags or adverse terms disclosed in re-appointment filing.
💡 Investor Takeaway
MD Ashish Ravi Puravankara secures 5-year re-appointment from April 2026 with enhanced remuneration through March 2029. Continuity confirmed across nine-city real estate portfolio including newly entered Mumbai redevelopment market.
⚖️ Strengths & Concerns

✅ Positives

  • MD continuity for 5-year term ensures strategic stability across nine-city portfolio and emerging Mumbai redevelopment operations.
  • Enhanced remuneration likely aligns MD incentives with company growth objectives across multiple geographies and segments.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses free when you sign up

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel